Virax Biolabs Group Limit... (VRAX)
NASDAQ: VRAX
· Real-Time Price · USD
0.76
-0.02 (-2.96%)
At close: Aug 19, 2025, 11:40 AM
Virax Biolabs Ratios and Metrics
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 | Sep 30, 2020 |
PE Ratio | n/a | -0.54 | -0.11 | -0.5 | -0.67 | -6.36 | -44.75 | -93.68 | -168.28 | -150.68 |
PEG Ratio | n/a | 0.01 | -0.03 | 0.01 | -0.01 | -0.29 | -0.41 | -1.15 | 16.83 | -0.08 |
PS Ratio | n/a | 1.21K | 20.54 | 75.42 | 3.86K | 6.38K | -2.23K | n/a | 1.88K | 14.79K |
PB Ratio | n/a | 0.70 | 0.31 | 0.91 | 1.18 | 8.36 | -212.41 | -278.1 | -347.22 | n/a |
P/FCF Ratio | n/a | -2.77 | -0.51 | -1.38 | -5.24 | -16 | -390.3 | -742.81 | -1.21K | -493.52 |
P/OCF Ratio | n/a | -3.13 | -0.59 | -1.67 | -5.74 | -16 | -390.3 | -742.81 | -1.21K | -493.52 |
OCF/S Ratio | n/a | -387.37 | -34.9 | -45.2 | -672.36 | -398.7 | 5.71 | n/a | -1.55 | -29.96 |
Debt / Equity Ratio | 0.07 | 0.07 | 0.04 | 0.03 | 0.02 | 0.00 | -0.00 | -0.24 | -0.3 | n/a |
Quick Ratio | 7.13 | 11.20 | 25.58 | 7.56 | 10.58 | 4.64 | 0.02 | 0.02 | 0.02 | n/a |
Current Ratio | 7.27 | 11.58 | 25.94 | 7.59 | 10.61 | 4.64 | 0.04 | 0.04 | 0.05 | n/a |
Asset Turnover | n/a | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | -1.91 | n/a | 1.17 | n/a |
Interest Coverage | n/a | -112.5 | -226.09 | -267.57 | -732.46 | -149.94 | -901.81 | -40.07 | -25.97 | -20.49 |
Return on Equity | n/a | -0.32 | -0.71 | -0.46 | -0.44 | -0.33 | 1.19 | 0.74 | 0.52 | n/a |
Return on Assets | n/a | -0.29 | -0.7 | -0.41 | -0.41 | -0.27 | -23.74 | -5.66 | -3.27 | n/a |
Return on Invested Capital | n/a | -0.3 | -0.71 | -0.43 | -0.47 | -0.35 | 0.98 | 0.67 | 0.35 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -1.31 | 0.50 | 0.14 | -0.53 | 0.02 | 2.08 | n/a | -0.21 | 1.00 |
Net Profit Margin | n/a | -556.52 | -47.85 | -38.03 | -1.43K | -250.63 | 12.45 | n/a | -2.8 | -24.53 |
Pretax Profit Margin | n/a | -584.14 | -47.86 | -38.09 | -1.43K | -252.39 | 12.65 | n/a | -2.58 | -27.83 |
Operating Profit Margin | n/a | -581.24 | -47.43 | -35.38 | -1.53K | -250.1 | 12.57 | n/a | -2.49 | -26.53 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -558.61 | -46.58 | -35.14 | 104.99 | -0.62 | 12.82 | n/a | 0.00 | 0.00 |